Cardiomyopathies and Related Changes in Contractility of Human Heart Muscle
Open Access
- 31 July 2018
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (8) , 2234
Abstract
About half of hypertrophic and dilated cardiomyopathies cases have been recognized as genetic diseases with mutations in sarcomeric proteins. The sarcomeric proteins are involved in cardiomyocyte contractility and its regulation, and play a structural role. Mutations in non-sarcomeric proteins may induce changes in cell signaling pathways that modify contractile response of heart muscle. These facts strongly suggest that contractile dysfunction plays a central role in initiation and progression of cardiomyopathies. In fact, abnormalities in contractile mechanics of myofibrils have been discovered. However, it has not been revealed how these mutations increase risk for cardiomyopathy and cause the disease. Much research has been done and still much is being done to understand how the mechanism works. Here, we review the facts of cardiac myofilament contractility in patients with cardiomyopathy and heart failure.Keywords
Funding Information
- British Heart Foundation (PG/17/5/32705)
This publication has 120 references indexed in Scilit:
- Truncations of Titin Causing Dilated CardiomyopathyNew England Journal of Medicine, 2012
- Molecular Mechanism of the E99K Mutation in Cardiac Actin (ACTC Gene) That Causes Apical Hypertrophy in Man and MouseJournal of Biological Chemistry, 2011
- Unequal allelic expression of wild-type and mutated β-myosin in familial hypertrophic cardiomyopathyBasic Research in Cardiology, 2011
- Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathyJournal of Molecular and Cellular Cardiology, 2010
- Static and dynamic properties of the HCM myocardiumJournal of Molecular and Cellular Cardiology, 2010
- Rate-dependent action potential alternans in human heart failure implicates abnormal intracellular calcium handlingHeart Rhythm, 2010
- Effect of troponin I Ser23/24 phosphorylation on Ca2+-sensitivity in human myocardium depends on the phosphorylation backgroundJournal of Molecular and Cellular Cardiology, 2010
- A piece of the human heart: variance of protein phosphorylation in left ventricular samples from end-stage primary cardiomyopathy patientsJournal of Muscle Research and Cell Motility, 2009
- The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathyCardiovascular Research, 2008
- Underlying Causes and Long-Term Survival in Patients with Initially Unexplained CardiomyopathyNew England Journal of Medicine, 2000